zidovudine has been researched along with Cardiovascular Diseases in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (70.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, K; Cotton, MF; Frigati, LJ; Githinji, L; Gray, D; Hoare, J; Mahtab, S; Myer, L; Nourse, P; Stein, DJ; Zar, HJ; Zühlke, L | 1 |
| Arnett, DK; Bagchi, S; Chi, BH; Heimburger, DC; Kabagambe, EK; Kiage, JN; Koethe, JR; Nyirenda, CK; Wellons, MF | 1 |
| Arnoczy, G; Campbell, T; Fichtenbaum, CJ; Ha, B; Hicks, C; Koletar, S; Massengale, K; McComsey, GA; Sax, P; Stein, JH; Taiwo, B; Tebas, P; Walsh, K; Wohl, DA | 1 |
| Bentata, M; Chêne, G; Collin, F; Garré, M; Goujard, C; Lafaurie, M; Leport, C; Levy, Y; Molina, JM | 1 |
| Chmielinska, JJ; Kramer, JH; Mak, IT; Weglicki, WB | 1 |
| Benfield, T; Kjaer, A; Kofoed, K; Kristoffersen, US; Kronborg, G; Lebech, AM | 1 |
| Nolan, D | 1 |
| Bernard, EJ | 1 |
| Nelson, M; Waters, L | 1 |
| Barbaro, G | 1 |
3 review(s) available for zidovudine and Cardiovascular Diseases
| Article | Year |
|---|---|
Do non-nucleoside reverse transcriptase inhibitors contribute to lipodystrophy?
Topics: Alkynes; Anti-Retroviral Agents; Benzoxazines; Cardiovascular Diseases; Cyclopropanes; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Metabolic Syndrome; Nevirapine; Oxazines; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Risk Factors; Stavudine; Zidovudine | 2005 |
Long-term complications of antiretroviral therapy: lipoatrophy.
Topics: Anti-HIV Agents; Body Image; Cardiovascular Diseases; Female; HIV-Associated Lipodystrophy Syndrome; Humans; Male; Stavudine; Time Factors; Zidovudine | 2007 |
Cardiovascular manifestations of HIV infection.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cardiomyopathy, Dilated; Cardiovascular Diseases; Child; Coronary Disease; Endocarditis, Bacterial; HIV Infections; Humans; Hypertension; Hypertension, Pulmonary; Immunoglobulins, Intravenous; Myocarditis; Myocardium; Nutrition Disorders; Pericardial Effusion; Ventricular Dysfunction, Right; Zidovudine | 2001 |
1 trial(s) available for zidovudine and Cardiovascular Diseases
| Article | Year |
|---|---|
Switch from zidovudine- to non-zidovudine-containing regimens is associated with modest haematological improvement and no obvious clinical benefit: a substudy of the ANRS 099 ALIZE trial.
Topics: Adult; Alkynes; Anti-HIV Agents; Bacterial Infections; Benzoxazines; Blood Platelets; Cardiovascular Diseases; Cyclopropanes; Deoxycytidine; Didanosine; Emtricitabine; Female; Hemoglobins; HIV Infections; Humans; Leukocyte Count; Male; Middle Aged; Neutrophils; Pancytopenia; Platelet Count; Prevalence; Zidovudine | 2008 |
6 other study(ies) available for zidovudine and Cardiovascular Diseases
| Article | Year |
|---|---|
Multisystem impairment in South African adolescents with Perinatally acquired HIV on antiretroviral therapy (ART).
Topics: Adolescent; Anti-Retroviral Agents; Cardiovascular Diseases; CD4 Lymphocyte Count; Child; Cognition Disorders; Cross-Sectional Studies; Dideoxynucleosides; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Kidney Diseases; Male; Respiratory Tract Diseases; South Africa; Viral Load; Zidovudine | 2019 |
Cardiometabolic risk factors among HIV patients on antiretroviral therapy.
Topics: Adenine; Adolescent; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Cyclopropanes; Female; HIV; HIV Infections; Humans; Insulin Resistance; Lamivudine; Male; Middle Aged; Nevirapine; Organophosphonates; Risk Factors; Stavudine; Tenofovir; Triglycerides; Zambia; Zidovudine | 2013 |
Comparison of cardiovascular disease risk markers in HIV-infected patients receiving abacavir and tenofovir: the nucleoside inflammation, coagulation and endothelial function (NICE) study.
Topics: Adenine; Adult; Anti-HIV Agents; Biomarkers; Blood Coagulation; Cardiovascular Diseases; Dideoxynucleosides; Endothelium, Vascular; Female; HIV Infections; Humans; Inflammation; Male; Middle Aged; Organophosphonates; Risk Factors; Tenofovir; Zidovudine | 2014 |
AZT-induced oxidative cardiovascular toxicity: attenuation by Mg-supplementation.
Topics: Animals; Cardiovascular Diseases; Dietary Supplements; Magnesium; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Zidovudine | 2009 |
Changes in biomarkers of cardiovascular risk after a switch to abacavir in HIV-1-infected individuals receiving combination antiretroviral therapy.
Topics: Adult; Aged; Anti-Retroviral Agents; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Dideoxynucleosides; Drug Therapy, Combination; Female; HIV Infections; Humans; Intercellular Adhesion Molecule-1; Longitudinal Studies; Male; Matrix Metalloproteinase 9; Middle Aged; Peroxidase; Risk Factors; Vascular Cell Adhesion Molecule-1; Viral Load; Zidovudine | 2009 |
ZDV link to early signs of CVD?
Topics: Cardiovascular Diseases; Drug Therapy, Combination; HIV Protease Inhibitors; Humans; Reverse Transcriptase Inhibitors; Zidovudine | 2006 |